Form 8-K · Current report

Zimmer Biomet 8-K, filed Sep 8, 2026

Filed
CIK
0001136869
Accession no.
0001193125-26-385256
AI-generated summary

Summary

Zimmer Biomet said Kevin Thornal, Group President, Global Businesses and the Americas, will depart on September 30, 2026, and announced promotions effective October 1 of Gary Campbell to President, Americas, Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery, and Bradley Kessler to President, Americas – Robotics, Technology and Data. The company reiterated its full-year 2026 financial outlook, and CEO Ivan Tornos said the promotions support its U.S. go-to-market transformation and expressed confidence in the 2026 outlook and growth potential in 2027 and beyond.

Key points

  • Kevin Thornal, Group President, Global Businesses and the Americas, will leave Zimmer Biomet effective September 30, 2026, and is eligible for severance benefits under the company's Restated Executive Severance Plan.
  • Effective October 1, Gary Campbell is promoted to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data.
  • Zimmer Biomet reiterated its full-year 2026 financial outlook provided on August 5, 2026.
  • Bradley Kessler will lead expansion of the company's specialized robotics salesforce ahead of the expected 2027 launch of the Monogram next-generation orthopedic robot.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 7.01Regulation FD Disclosure
  • 9.01Financial Statements and Exhibits

From the filing

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 8, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) notified Kevin Thornal, Group President, Global Businesses and the Americas, that his position is being restructured. Mr. Thornal will be departing from the Company, effective on September 30, 2026. Mr. Thornal will be eligible for severance benefits under the Company’s Restated Executive Severance Plan, as amended (the “Severance Plan”). Pursuant to the Severance Plan, Mr. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Zimmer Biomet in Readster

Add Zimmer Biomet to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.